BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 7, 2025
See today's BioWorld
See today's BioWorld MedTech
Home
» Astellas-Yaskawa JV to build robot-based cell production platform
To read the full story,
subscribe
or
sign in
.
Astellas-Yaskawa JV to build robot-based cell production platform
March 6, 2025
By
Marian (YoonJee) Chu
Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform using Yaskawa’s dual-arm humanoid robot called Maholo.
BioWorld
BioWorld MedTech
Deals and M&A
Newco news
Cell therapy
Robotic surgery
Asia-Pacific